Qube Research & Technologies LTD X Biotech Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in X Biotech Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 32,218 shares of XBIT stock, worth $73,134. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,218Holding current value
$73,134% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding XBIT
# of Institutions
52Shares Held
4.4MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$2.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA819KShares$1.86 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny551KShares$1.25 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$563,5720.0% of portfolio
-
Geode Capital Management, LLC Boston, MA221KShares$500,9410.0% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $69.1M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...